Rachel Yehuda1, Sarah Brand, Ren-Kui Yang. 1. Traumatic Stress Studies Program, Psychiatry Department, Mount Sinai School of Medicine, and the Bronx Veterans Affairs Medical Center, New York, New York 10468, USA. Rachel.Yehuda@med.va.gov
Abstract
BACKGROUND: There is emerging interest in examining the role of plasma neuropeptide Y (NPY) as a protective stress factor. METHODS: To further investigate this possibility, plasma NPY was measured in 11 nonexposed veterans, 11 combat-exposed veterans without posttraumatic stress disorder (PTSD), and 12 veterans with current PTSD. RESULTS: A significant group difference in plasma NPY (F(2,31) = 5.16, p = .012) was observed, reflecting higher NPY levels in exposed veterans without PTSD than in nonexposed but comparable levels in veterans with current PTSD. Among those without current PTSD, veterans with past PTSD had higher NPY levels than those without past PTSD (t(9) = 2.71, p = .024). After controlling for all other variables, NPY levels were significantly predicted by extent of symptom improvement and lower combat exposure and significant at a trend level with positive coping. CONCLUSIONS: Plasma NPY levels may represent a biologic correlate of resilience to or recovery from the adverse effects of stress.
BACKGROUND: There is emerging interest in examining the role of plasma neuropeptide Y (NPY) as a protective stress factor. METHODS: To further investigate this possibility, plasma NPY was measured in 11 nonexposed veterans, 11 combat-exposed veterans without posttraumatic stress disorder (PTSD), and 12 veterans with current PTSD. RESULTS: A significant group difference in plasma NPY (F(2,31) = 5.16, p = .012) was observed, reflecting higher NPY levels in exposed veterans without PTSD than in nonexposed but comparable levels in veterans with current PTSD. Among those without current PTSD, veterans with past PTSD had higher NPY levels than those without past PTSD (t(9) = 2.71, p = .024). After controlling for all other variables, NPY levels were significantly predicted by extent of symptom improvement and lower combat exposure and significant at a trend level with positive coping. CONCLUSIONS: Plasma NPY levels may represent a biologic correlate of resilience to or recovery from the adverse effects of stress.
Authors: Wolfgang H Sommer; Jessica Lidström; Hui Sun; Derek Passer; Robert Eskay; Stephen C J Parker; Stephanie H Witt; Ulrich S Zimmermann; Vanessa Nieratschker; Marcella Rietschel; Elliott H Margulies; Miklós Palkovits; Manfred Laucht; Markus Heilig Journal: Hum Mutat Date: 2010-08 Impact factor: 4.878
Authors: Rachel Yehuda; Laura C Pratchett; Matthew W Elmes; Amy Lehrner; Nikolaos P Daskalakis; Erin Koch; Iouri Makotkine; Janine D Flory; Linda M Bierer Journal: Interface Focus Date: 2014-10-06 Impact factor: 3.906
Authors: James P Mackay; Maria Bompolaki; M Regina DeJoseph; Sheldon D Michaelson; Janice H Urban; William F Colmers Journal: J Neurosci Date: 2019-04-10 Impact factor: 6.167
Authors: Richard Lieberman; Stephen Armeli; Denise M Scott; Henry R Kranzler; Howard Tennen; Jonathan Covault Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2016-05-19 Impact factor: 3.568